Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
Abstract We describe a 51‐year‐old otherwise healthy woman hospitalized for hypotension, fever, and weakness 4 days after the second‐dose Covid‐19 mRNA vaccine. Elevated inflammatory markers, natriuretic peptide levels and troponin levels, and slightly reduced left ventricular ejection fraction of 5...
Main Authors: | Kosuke Kobayashi, Yasuhiro Hamatani, Koki Moriyoshi, Moritake Iguchi, Nobutoyo Masunaga, Mariko Terashima, Mitsuru Abe, Nozomu Sasahashi, Masaharu Akao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.14252 |
Similar Items
-
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children
by: Marion Grimaud, et al.
Published: (2020-06-01) -
Acute myocarditis and heart failure associated with multisystem inflammatory syndrome in adults: A rare sequela of coronavirus 2 infection
by: Sadeq Tabatabai, et al.
Published: (2022-01-01) -
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult
by: Alexandra Othenin-Girard, et al.
Published: (2020-11-01) -
Longitudinal Outcomes and Monitoring of Patients With Multisystem Inflammatory Syndrome in Children
by: Michael A. Fremed, et al.
Published: (2022-04-01) -
COVID-19-associated multisystem inflammatory syndrome in a child with fulminant myocarditis with successful outcome on extracorporeal membrane oxygenation: A case report
by: Prameela Joji, et al.
Published: (2022-01-01)